Since its establishment in 1995, the Agency has harmonised and improved the evaluation of medicines, stimulated innovation, improved safety monitoring and risk management, fostered transparency and dialogue, built relationships with international partners and helped to make medicines accessible to those who need them. To achieve this, EMA has worked closely with the national authorities in EU Member States, the European Commission, international partners and civil society.
Sandra Gallina, Director General for the European Commission's Directorate-General for Health and Food Safety, Cristian-Silviu Buşoi, Member of the European Parliament, Christa Wirthumer-Hoche, the Chair of EMA's Management Board, Thomas Senderovitz, the Chair of the Heads of Medicines Agencies (HMA) and Noël Wathion, EMA’s Deputy Executive Director, are among the speakers.
Executive Director Guido Rasi will talk about EMA’s key achievements and lessons learnt in the last 25 years, while Emer Cooke, who will take over at the helm of the Agency on 16 November, will present her reflections on the road ahead for medicines’ regulation, given the challenges and continually evolving landscape.
Key stakeholders representing patients, healthcare professionals, academia, industry and national and international partners have been invited to participate in an audience discussion, which will be moderated by Hans-Georg Eichler, EMA’s Senior Medical Officer
The full agenda is available on the event page. The event will be broadcast live.
The Agency will post Twitter messages during the event, which can be followed by using the hashtag #EMA25Years.
